ARCHIVES

Investigators Testing Ways To Overcome Gleevec Resistance: High Dose, New Drugs

This article is from The Cancer Letter archive.

Vol. 28 No. 1 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

AACR Calls For Clear Statement; Says Report Was “Premature”

February 14, 1997

Cooperative Group chairmen Cool, But High Priority Trials To Continue

January 18, 1991

Amgen’s Aranesp Sales Dropped By Half, Continue To Fall.

November 14, 2008

DCT Board Okays Bladder Cancer RFA From Organ Systems Program

June 6, 1986

DCE Board Oks Concept For Three Contracts In Radiation Epidemiology

June 29, 1984

Senate Votes To Invalidate Task Force Guideline

December 4, 2009